Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: Implications for malignant melanoma therapy

Molecular Cancer Therapeutics

Volumn 8, Issue 5, 2009, Pages 1292-1304

  Su, David M ^a   Zhang, Qiuyang ^a   Wang, Xuexi ^a,b   He, Ping ^c   Zhu, Yuelin Jack ^e   Zhao, Jianxiong ^b   Rennert, Owen M ^d   Su, Yan A ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b LANZHOU UNIVERSITY   (China)

^c Center for Biological Evaluation and Research

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; APAF1 GENE; API5 GENE; APOPTOSIS; ARTICLE; ATOX1 GENE; BAD GENE; BAK1 GENE; BCL2 GENE; BCL2A1 GENE; BNIP1 GENE; BNIP3L GENE; CANCER CELL CULTURE; CASP1 GENE; CASP2 GENE; CASP4 GENE; CASP7 GENE; CAT GENE; CELL SURVIVAL; CELL TYPE; CLUSTER ANALYSIS; CYCS GENE; DNA MICROARRAY; ENDOG GENE; FEMALE; FIS1 GENE; GENE EXPRESSION PROFILING; GLRX2 GENE; GPX4 GENE; GSR GENE; GSS GENE; HSPD1 GENE; HTRA2 GENE; HUMAN; HUMAN CELL; MALE; MELANOCYTE; MELANOMA; MITOCHONDRION; MT3 GENE; ONCOGENE; PDCD5 GENE; PPARD GENE; PPP2CA GENE; PPP2R1A GENE; PPP2R1B GENE; PRDX3 GENE; PRDX5 GENE; PRIORITY JOURNAL; PRODH GENE; PROGNOSIS; PSEN1 GENE; QUANTITATIVE ANALYSIS; RAF1 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPT4 GENE; SOD1 GENE; TNFSF10 GENE; VALIDATION PROCESS; VDAC1 GENE;

APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MITOCHONDRIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 66849132218     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-08-1030     Document Type: Article

References (35)

1. American Cancer Society. Cancer facts and figures 2008. Atlanta: American Cancer Society; 2008. p. 1-70. Available from: http://www.cancer.org.
2. Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature 2007;445:851-857 (Pubitemid 46309849)
3. MacKie RM, Bray C, Vestey J, et al. Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer 2007;96:1772-1777
4. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001;14:280-290 (Pubitemid 34701635)
5. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179-185 (Pubitemid 38352453)
6. Eigentler TK, Caroli UM, Radny P, Garbe C. Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncol 2003;4:748-759 (Pubitemid 37527210)
7. Schadendorf D, Ugurel S, Schuler-Thurner B, et al. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol 2006;17:563-570
8. Tuettenberg A, Schmitt E, Knop J, Jonuleit H. Dendritic cell-based immunotherapy of malignant melanoma: success and limitations. J Dtsch Dermatol Ges 2007;5:190-196 (Pubitemid 46361349)
9. Middleton MR, Grob JJ, Aaronson N, et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000;18:158-166 (Pubitemid 30036349)
10. Bedikian AY, Millward M, Pehamberger H, et al. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group. J Clin Oncol 2006;24:4738-4745 (Pubitemid 46630937)
11. Meier F, Satyamoorthy K, Nesbit M, et al. Molecular events in melanoma development and progression. Front Biosci 1998;3:D1005-10.
12. Kim R, Emi M, Tanabe K. The role of apoptosis in cancer cell survival and therapeutic outcome. Cancer Biol Ther 2006;5:1429-1442 (Pubitemid 46256609)
13. Zhang Q, Chen Y, Wang BD, He P, Su YA. Differences in apoptosis and cell cycle distribution between human melanoma cell lines UACC903 and UACC903(+6), before and after UV irradiation. Int J Biol Sci 2007;3:342-348
14. Zhang Q, Wu J, Nguyen A, et al. Molecular mechanism underlying differential apoptosis between human melanoma cell lines UACC903 and UACC903(+6) revealed by mitochondria-focused cDNA microarrays. Apoptosis 2008;13:993-1004.
15. Bai X, Wu J, Zhang Q, et al. Third-generation human mitochondria-focused cDNA microarray and its bioinformatic tools for analysis of gene expression. Biotechniques 2007;42:365-375
16. Su YA, Ray ME, Lin T, et al. Reversion of monochromosome-mediated suppression of tumorigenicity in malignant melanoma by retroviral transduction. Cancer Res 1996;56:3186-3191 (Pubitemid 26242958)
17. Trent JM, Stanbridge EJ, McBride HL, et al. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 1990;247:568-571 (Pubitemid 20073680)
18. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-193 (Pubitemid 36181903)
19. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-14868 (Pubitemid 29003722)
20. Manoli I, Le H, Alesci S, et al. Monoamine oxidase-A is a major target gene for glucocorticoids in human skeletal muscle cells. FASEB J 2005;19:1359-1361 (Pubitemid 41113749)
21. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A 1991;88:7276-7280 (Pubitemid 21915133)
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995;57:289-300.
23. Seftor EA, Meltzer PS, Kirschmann DA, et al. Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 2002;19:233-246 (Pubitemid 34553524)
24. Lee ML, Kuo FC, Whitmore GA, Sklar J. Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci U S A 2000;97:9834-9839
25. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003;22:3138-3151
26. Eberle J, Kurbanov BM, Hossini AM, Trefzer U, Fecker LF. Overcoming apoptosis deficiency of melanoma - hope for new therapeutic approaches. Drug Resist Updat 2007;10:218-234
27. Eberle J, Fecker LF, Forschner T, Ulrich C, Rowert-Huber J, Stockfleth E. Apoptosis pathways as promising targets for skin cancer therapy. Br J Dermatol 2007;156 Suppl 3:18-24. (Pubitemid 46632507)
28. Lin WM, Baker AC, Beroukhim R, et al. Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res 2008;68:664-673
29. Lorigan P, Eisen T, Hauschild A. Systemic therapy for metastatic malignant melanoma - from deeply disappointing to bright future? Exp Dermatol 2008;17:383-394
30. Ikoma N, Yamazaki H, Abe Y, et al. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/γCnull (NOG) mouse model. Oncol Rep 2005;14:633-637
31. Welch DR, Bisi JE, Miller BE, et al. Characterization of a highly-invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer 1991;47:227-237
32. Gouon V, Tucker GC, Kraus-Berthier L, Atassi G, Kieffer N. Up-regulated expression of the β3 integrin and the 92-kDa gelatinase in human HT-144 melanoma cell tumors grown in nude mice. Int J Cancer 1996;68:650-662 (Pubitemid 26414528)
33. Thies A, Mauer S, Fodstad O, Schumacher U. Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice. Br J Cancer 2007;96:609-616 (Pubitemid 46303536)
34. Luca M, Xie S, Gutman M, Huang S, Bar-Eli M. Abnormalities in the CDKN2 (p16INK4/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis. Oncogene 1995;11:1399-1402
35. Su YA, Bittner ML, Chen Y, et al. Identification of tumor-suppressor genes using human melanoma cell lines UACC903, UACC903(+6), and SRS3 by comparison of expression profiles. Mol Carcinog 2000;28:119-127